According to OptimizeRx's latest financial reports the company's current EPS (TTM) is -$1.30. In 2022 the company made an earnings per share (EPS) of -$1.00 a decrease over its 2021 EPS that were of $0.01949.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.23 | 23.28% |
2022 | -$1.00 | -5237.82% |
2021 | $0.01949 | -108.17% |
2020 | -$0.24 | -31.65% |
2019 | -$0.35 | -1197.3% |
2018 | $0.03179 | -109.09% |
2017 | -$0.35 | 46.67% |
2016 | -$0.24 | 137.24% |
2015 | -$0.10 | -57.85% |
2014 | -$0.24 | 400% |
2013 | -$0.04768 | -75% |
2012 | -$0.19 | -73.33% |
2011 | -$0.72 | -0% |
2010 | -$0.72 | -59.46% |
2009 | -$1.76 | -5.13% |
2008 | -$1.86 |